December 12, 2012
Astellas Pharma and UMN Pharma announced on December 11 that they have completed the administration of the recombinant seasonal influenza HA vaccine ASP7374 (former code: UMN-0502) for all subjects enrolled in the ongoing PIII trial. ASP7374 was administered to 1,020...read more